H. Mayles

发表

Caesium137 implant as sole radiation therapy for operable breast cancer: a phase II trial

I. Fentiman, M. Chaudary, V. Deshmane, 2004 .

A multicentre study of the evidence for customized margins in photon breast boost radiotherapy

P. Evans, J. Yarnold, C. Coles, 2015, The British journal of radiology.

Iridium implant treatment without external radiotherapy for operable breast cancer: a pilot study.

I. Fentiman, C. Poole, R. Rubens, 1991, European journal of cancer.

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

I. Ellis, P. Evans, M. Sculpher, 2017, The Lancet.

Planning with intensity-modulated radiotherapy and tomotherapy to modulate dose across breast to reflect recurrence risk (IMPORT High trial).

J. Yarnold, C. Coles, J. Fairfoul, 2011, International journal of radiation oncology, biology, physics.

Comparison of hypofractionated high-dose intensity-modulated radiotherapy schedules for prostate cancer: Results from the phase III randomized CHHiP trial (CRUK/06/016).

D. Dearnaley, V. Khoo, J. Logue, 2016 .

Caesium(137) implant as sole radiation therapy for operable breast cancer: a phase II trial.

I. Fentiman, M. Chaudary, V. Deshmane, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Physical aspects of interstitial therapy using flexible iridium-192 wire.

W. Mayles, H. Mayles, P. C. Turner, 1985, The British journal of radiology.

Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas.

B. Damato, H. Mayles, I. Campbell, 2005, International journal of radiation oncology, biology, physics.

Local tumor control after 106Ru brachytherapy of choroidal melanoma.

B. Damato, H. Mayles, I. Campbell, 2005, International journal of radiation oncology, biology, physics.

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Annie Gao, Clare Griffin, John Staffurth, 2016, The Lancet. Oncology.

A multicentre observational study evaluating image-guided radiotherapy for more accurate partial-breast intensity-modulated radiotherapy: comparison with standard imaging technique

H. Bartelink, P. Evans, J. Yarnold, 2014 .

Inadequacy of iridium implant as sole radiation treatment for operable breast cancer.

I. Fentiman, W. Gregory, C. Poole, 1996, European journal of cancer.

Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial

D. Dearnaley, V. Khoo, C. Parker, 2019, Clinical and translational radiation oncology.

IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer

D. Landau, E. Miles, J. Spicer, 2016, International journal of radiation oncology, biology, physics.

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial.

Annie Gao, John Staffurth, Peter Kirkbride, 2012, The Lancet. Oncology.

Assessment of skin dose and its relation to cosmesis in the conservative treatment of early breast cancer.

I. Fentiman, J. Hayward, W. Mayles, 1988, International journal of radiation oncology, biology, physics.

PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)

J. Staffurth, A. Henry, C. Cruickshank, 2020, Clinical and translational radiation oncology.

148 Dose escalation in the I-START trial – ISoToxic Accelerated RadioTherapy in locally advanced non-small cell lung cancer

A. Nahum, A. Ionescu, J. Lester, 2014 .

Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)

D. Dearnaley, V. Khoo, J. Staffurth, 2019, International journal of radiation oncology, biology, physics.

Separating components of variation in measurement series using maximum likelihood estimation. Application to patient position data in radiotherapy

J P Sage, W P M Mayles, H M Mayles, 2014, Physics in medicine and biology.

A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer

D. Dearnaley, V. Khoo, C. Parker, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity

D. Dearnaley, V. Khoo, S. Hassan, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

156 The I-START trial: ISoToxic Accelerated RadioTherapy in locally advanced non-small cell lung cancer

John D. Fenwick, Lisette Sheena Nixon, Alan E. Nahum, 2012 .

A national dosimetry audit for stereotactic ablative radiotherapy in lung.

C. Clark, C. Baker, C. Gouldstone, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer.

D. Dearnaley, V. Khoo, C. Clark, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

8LBA 5 year outcomes of a phase III randomised trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): report from the CHHiP Trial Investigators Group

D. Dearnaley, V. Khoo, J. Logue, 2015 .

Planning with intensity-modulated radiotherapy and tomotherapy to modulate dose across breast to reflect recurrence risk (IMPORT High trial).

J. Yarnold, C. Coles, J. Fairfoul, 2011, International Journal of Radiation Oncology, Biology, Physics.

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

D. Dearnaley, V. Khoo, C. Parker, 2016, The Lancet. Oncology.

Title : A randomised assessment of image guided radiotherapy within a phase 3 trial of Conventional or Hypofractionated High Dose Intensity Modulated Radiotherapy for Prostate Cancer ( CHHiP )

Parker, D. Dearnaley, V. Khoo, 2018 .

IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer

Y. Ngai, M. Illsley, W. Mayles, 2016, International journal of radiation oncology, biology, physics.

Title Radiotherapy Quality Assurance for the CHHiP Trial : Conventional versus Hypofractionated High-dose Intensity-modulated Radiotherapy in Prostate Cancer

D. Dearnaley, V. Khoo, C. Clark, 2019 .

Feasibility study of silica bead thermoluminescence detectors (TLDs) in an external radiotherapy dosimetry audit programme

C. Clark, A. Nisbet, C. Gouldstone, 2017 .